60Co与192Ir高剂量率腔内-组织间插植近距离放疗治疗宫颈癌的放射生物学与剂量学比较
纳入30例接受高剂量率腔内-组织间插植近距离放疗的宫颈癌患者,为每例分别设计60Co与192Ir计划,处方剂量CTV D90=6 Gy。60Co与192Ir的剂量学参数可比,肿瘤EUD与TCP无统计学差异,而60Co对危及器官保护更好且经济优势明显,可作为192Ir的良好替代方案推广。
要点
- 60Co与192Ir计划的肿瘤EUD(93.93 vs 93.92 Gy)与TCP(97.07% vs 97.08%)无统计学差异。
- 60Co危及器官平均物理剂量和EQD2低于192Ir,D2cc与D1cc差异有统计学意义(p<0.05)。
- 60Co平均NTCP值低于192Ir,作者认为60Co可保证相似肿瘤控制概率并更好保护危及器官。
核心结论
- 综合CTV与危及器官考虑,60Co与192Ir的剂量学参数可比。
- 与192Ir相比,60Co用于高剂量率腔内-组织间插植近距离放疗可保证相似的肿瘤控制概率,同时提供更好的危及器官保护。
- 60Co具有明显的经济优势,可作为192Ir的良好替代方案推广。
研究设计与样本
- 本研究纳入30例接受高剂量率腔内-组织间插植近距离放疗的宫颈癌患者。
- 为每例患者分别设计60Co与192Ir计划,处方剂量为CTV D90=6 Gy,并尽可能降低危及器官剂量。
- 从治疗计划系统提取CTV与危及器官的物理剂量和剂量体积参数,用相应公式计算EQD2、EUBED、EUD、TCP与NTCP。
- 采用配对t检验比较60Co与192Ir计划的差异。
主要发现
- 每例患者的60Co与192Ir计划中,60Co的平均物理剂量和EQD2低于192Ir。
- 危及器官D2cc与D1cc在60Co与192Ir间差异有统计学意义(p<0.05)。
- 膀胱D0.1 cc在60Co与192Ir间差异有统计学意义(p<0.05),直肠与肠道D0.1 cc无显著差异(p>0.05)。
- CTV的EUBED比值(60Co/192Ir)在两者均未过半衰期或均过两个半衰期时多接近1,差异不显著;危及器官处60Co均值低于192Ir。
- 肿瘤EUD(93.93 vs 93.92 Gy,p>0.05)与TCP(97.07% vs 97.08%,p>0.05)在60Co与192Ir间无统计学差异;60Co平均NTCP值低于192Ir。
关键数值与推荐
- 处方剂量为CTV D90=6 Gy。
- 肿瘤EUD:60Co 93.93 Gy vs 192Ir 93.92 Gy,p>0.05。
- 肿瘤TCP:60Co 97.07% vs 192Ir 97.08%,p>0.05。
临床怎么用
- 作者认为60Co可作为192Ir的良好替代方案用于高剂量率腔内-组织间插植近距离放疗并推广。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-dose-rate (HDR) intracavitary-interstitial brachytherapy (IC-ISBT) is an effective treatment for bulky, middle, and advanced cervical cancer. In this study, we compared the differences between 60Co and 192Ir HDR IC-ISBT plans in terms of radiobiological and dosimetric parameters, providing a reference for clinical workers in brachytherapy. METHODS: A total of 30 patients with cervical cancer receiving HDR IC-ISBT were included in this study, and IC-ISBT plans for each individual were designed with both 60Co and 192Ir at a prescribed dose of CTV D90 = 6 Gy while keeping the dose to OARs as low as possible. Physical dose and dose-volume parameters of CTV and OARs were extracted from TPS. The EQD2, EUBED, EUD, TCP, and NTCP were calculated using corresponding formulas. The differences between the 60Co and 192Ir IC-ISBT plans were compared using the paired t-test. RESULTS: In each patient's 60Co and 192Ir IC-ISBT plan, the average physical dose and EQD2 of 60Co were lower than those of 192Ir, and there were statistically significant differences in D2cc and D1cc for the OARs (p < 0.05); there were statistically significant differences in D0.1 cc for the bladder (p < 0.05) and no significant differences in D0.1 cc for the rectum or intestines (p > 0.05). The EUBED ratio (60Co/192Ir) at the CTV was mostly close to 1 when neither 60Co or 192Ir passed their half-lives or when both passed two half-lives, and the difference between them was not significant; at the OARs, the mean value of 60Co was lower than that of 192Ir. There was no statistical difference between 60Co and 192Ir in the EUD (93.93 versus 93.92 Gy, p > 0.05) and TCP (97.07% versus 97.08%, p > 0.05) of the tumors. The mean NTCP value of 60Co was lower than that of 192Ir. CONCLUSIONS: Considering the CTV and OARs, the dosimetric parameters of 60Co and 192Ir are comparable. Compared with 192Ir, the use of 60Co for HDR IC-ISBT can ensure a similar tumor control probability while providing better protection to the OARs. In addition, 60Co has obvious economic advantages and can be promoted as a good alternative to 192Ir.
引用
- Wen A, Wang X, Wang B, et al. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer. Radiat Oncol. 2022. PMID: 36514118. doi:10.1186/s13014-022-02170-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。